Abstract
Lipopolysaccharide-induced tumor necrosis factor alpha factor (LITAF), also called p53-induced gene 7 (PIG7), was identified as a transcription factor that activates transcription of proinflammatory cytokines in macrophages in response to lipopolysaccharide (LPS). Previous studies have identified LITAF as a potential tumor suppressor in several neoplasms, including prostate cancer, B-NHL, acute myeloid leukemia, and pancreatic cancer. However, the expression and function of LITAF in human glioma remain unexplained. The present study aimed to analyze the regulation of LITAF in gliomas. Data from The Cancer Genome Atlas (TCGA) database revealed that LITAF mRNA expression in glioma tissues was higher than that in normal brain tissues, and lower LITAF expression in gliomas showed a good prognosis in patients who received radiotherapy, by Kaplan–Meier analysis. In our collected specimens, however, LITAF showed low expression in glioma tissues compared to that in the normal brain tissue. Proliferation and apoptosis of glioma cells were not affected by knockdown or overexpression of LITAF in glioma U251, U373, and U87 cells, but LITAF was able to enhance the radiosensitivity of glioma cells. Furthermore, we found that LITAF enhanced radiosensitivity via FoxO1 and its specific downstream targets BIM, TRAIL, and FASLG. Taken together, our present results demonstrate that LITAF expression is decreased in glioma tissues and might enhance radiosensitivity of glioma cells via upregulation of the FoxO1 pathway.
Similar content being viewed by others
References
Agnihotri S, Burrell KE, Wolf A, Jalali S, Hawkins C, Rutka JT, Zadeh G (2013) Glioblastoma, a brief review of history, molecular genetics, animal models and novel therapeutic strategies. Arch Immunol Ther Exp 61:25–41
Alikhani M, Alikhani Z, Graves DT (2005) FOXO1 functions as a master switch that regulates gene expression necessary for tumor necrosis factor-induced fibroblast apoptosis. J Biol Chem 280:12096–12102
Bertolo C, Roa S, Sagardoy A, Mena-Varas M, Robles EF, Martinez-Ferrandis JI, Sagaert X, Tousseyn T, Orta A, Lossos IS, Amar S, Natkunam Y, Briones J, Melnick A, Malumbres R, Martinez-Climent JA (2013) LITAF, a BCL6 target gene, regulates autophagy in mature B-cell lymphomas. Br J Haematol 162:621–630
Bois PRJ, Izeradjene K, Houghton PJ, Cleveland JL, Houghton JA, Grosveld GC (2005) FOXO1a acts as a selective tumor suppressor in alveolar rhabdomyosarcoma. J Cell Biol 170:903–912
Gallego O (2015) Nonsurgical treatment of recurrent glioblastoma. Curr Oncol 22:e273–e281
Gilley J, Coffer PJ, Ham J (2003) FOXO transcription factors directly activate bim gene expression and promote apoptosis in sympathetic neurons. J Cell Biol 162:613–622
Hoey C, Ray J, Jeon J, Huang X, Taeb S, Ylanko J, Andrews DW, Boutros PC, Liu SK (2018) miRNA-106a and prostate cancer radioresistance: a novel role for LITAF in ATM regulation. Mol Oncol 12:1324–1341
Ito Y, Daitoku H, Fukamizu A (2009) Foxo1 increases pro-inflammatory gene expression by inducing C/EBPbeta in TNF-alpha-treated adipocytes. Biochem Biophys Res Commun 378:290–295
Jiang S, Li T, Yang Z, Hu W, Yang Y (2018) Deciphering the roles of FOXO1 in human neoplasms. Int J Cancer 143(7):1560–1568
Kayal RA, Siqueira M, Alblowi J, McLean J, Krothapalli N, Faibish D, Einhorn TA, Gerstenfeld LC, Graves DT (2010) TNF-α mediates diabetes-enhanced chondrocyte apoptosis during fracture healing and stimulates chondrocyte apoptosis Through FOXO1. J Bone Miner Res 25:1604–1615
Lapointe S, Perry A, Butowski NA (2018) Primary brain tumours in adults. Lancet 392:432–446
Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW (2016) The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131:803–820
Merrill JC, You J, Constable C, Leeman SE, Amar S (2011) Whole-body deletion of LPS-induced TNF-alpha factor (LITAF) markedly improves experimental endotoxic shock and inflammatory arthritis. Proc Natl Acad Sci USA 108:21247–21252
Mestre-Escorihuela C, Rubio-Moscardo F, Richter JA, Siebert R, Climent J, Fresquet V, Beltran E, Agirre X, Marugan I, Marin M, Rosenwald A, Sugimoto KJ, Wheat LM, Karran EL, Garcia JF, Sanchez L, Prosper F, Staudt LM, Pinkel D, Dyer MJS, Martinez-Climent JA (2007) Homozygous deletions localize novel tumor suppressor genes in B-cell lymphomas. Blood 109:271–280
Myokai F, Takashiba S, Lebo R, Amar S (1999) A novel lipopolysaccharide-induced transcription factor regulating tumor necrosis factor alpha gene expression: molecular cloning, sequencing, characterization, and chromosomal assignment. Proc Natl Acad Sci USA 96:4518–4523
Ostrom QT, Gittleman H, Liao P, Vecchione-Koval T, Wolinsky Y, Kruchko C, Barnholtz-Sloan JS (2017) CBTRUS Statistical Report: primary brain and other central nervous system tumors diagnosed in the United States in 2010-2014. Neuro Oncol 19:v1–v88
Polyak K, Xia Y, Zweier JL, Kinzler KW, Vogelstein B (1997) A model for p53-induced apoptosis. Nature 389:300–305
Schijns V, Pretto C, Strik AM, Gloudemans-Rijkers R, Deviller L, Pierre D, Chung J, Dandekar M, Carrillo JA, Kong XT, Fu BD, Hsu F, Hofman FM, Chen TC, Zidovetzki R, Bota DA, Stathopoulos A (2018) Therapeutic Immunization against glioblastoma. Int J Mol Sci 19:2540
Stucchi A, Reed K, O’Brien M, Cerda S, Andrews C, Gower A, Bushell K, Amar S, Leeman S, Becker J (2006) A new transcription factor that regulates TNF-alpha gene expression, LITAF, is increased in intestinal tissues from patients with CD and UC. Inflamm Bowel Dis 12:581–587
Tang X, Marciano DL, Leeman SE, Amar S (2005) LPS induces the interaction of a transcription factor, LPS-induced TNF-alpha factor, and STAT6(B) with effects on multiple cytokines. Proc Natl Acad Sci USA 102:5132–5137
Tang X, Metzger D, Leeman S, Amar S (2006) LPS-induced TNF-alpha factor (LITAF)-deficient mice express reduced LPS-induced cytokine: evidence for LITAF-dependent LPS signaling pathways. Proc Natl Acad Sci USA 103:13777–13782
Tang X, Woodward T, Amar S (2010) A PTP4A3 peptide PIMAP39 modulates TNF-alpha levels and endotoxic shock. J Innate Immun 2:43–55
Wang D, Liu J, Tang K, Xu Z, Xiong X, Rao Q, Wang M, Wang J (2009) Expression of pig7 gene in acute leukemia and its potential to modulate the chemosensitivity of leukemic cells. Leuk Res 33:28–38
Wang J, Shi Y, Wang L, Ren G, Bai Y, Shi H, Zhang X, Jiang X, Zhou R (2014a) Significance of expression and promoter methylation of LITAF gene in B-cell lymphoma. Zhonghua Bing Li Xue Za Zhi 43:516–521
Wang XW, Yu Y, Gu L (2014b) Dehydroabietic acid reverses TNF-alpha-induced the activation of FOXO1 and suppression of TGF-beta1/Smad signaling in human adult dermal fibroblasts. Int J Clin Exp Pathol 7:8616–8626
Wesseling P, Capper D (2018) WHO 2016 classification of gliomas. Neuropathol Appl Neurobiol 44:139–150
Wu Y, Elshimali Y, Sarkissyan M, Mohamed H, Clayton S, Vadgama JV (2012) Expression of FOXO1 is associated with GATA3 and Annexin-1 and predicts disease-free survival in breast cancer. Am J Cancer Res 2:104–115
Xie L, Ushmorov A, Leithauser F, Guan H, Steidl C, Farbinger J, Pelzer C, Vogel MJ, Maier HJ, Gascoyne RD, Moller P, Wirth T (2012) FOXO1 is a tumor suppressor in classical Hodgkin lymphoma. Blood 119:3503–3511
Yan H, Wu A (2018) FOXO1 is crucial in glioblastoma cell tumorigenesis and regulates the expression of SIRT1 to suppress senescence in the brain. Mol Med Rep 17:2535–2542
Zhang Y, Gan B, Liu D, Paik J (2011) FoxO family members in cancer. Cancer Biol Ther 12:253–259
Zhao M, Luo R, Liu Y, Gao L, Fu Z, Fu Q, Luo X, Chen Y, Deng X, Liang Z, Li X, Cheng C, Liu Z, Fang W (2016) miR-3188 regulates nasopharyngeal carcinoma proliferation and chemosensitivity through a FOXO1-modulated positive feedback loop with mTOR–p-PI3 K/AKT-c-JUN. Nat Commun 7:11309
Zheng J, Zou J, Wang W, Feng X, Shi Y, Zhao Y, Jin G, Liu Z (2011) Tumor necrosis factor-α increases angiopoietin-like protein 2 gene expression by activating Foxo1 in 3T3-L1 adipocytes. Mol Cell Endocrinol 339:120–129
Zhou J, Yang Z, Tsuji T, Gong J, Xie J, Chen C, Li W, Amar S, Luo Z (2011) LITAF and TNFSF15, two downstream targets of AMPK, exert inhibitory effects on tumor growth. Oncogene 30:1892–1900
Zhou Y, Huang J, Yu X, Jiang X, Shi Y, Weng Y, Kuai Y, Lei L, Ren G, Feng X, Zhong G, Liu Q, Pan H, Zhang X, Zhou R, Lu C (2018) LITAF is a potential tumor suppressor in pancreatic cancer. Oncotarget 9:3131–3142
Zou J, Guo P, Lv N, Huang D (2015) Lipopolysaccharide-induced tumor necrosis factor-alpha factor enhances inflammation and is associated with cancer. Mol Med Rep 12:6399–6404
Funding
This study was funded by the National Natural Science Foundation of China (No. 81372408).
Author information
Authors and Affiliations
Contributions
CH, DC, and HZ performed the experiments and analyzed the data. SL and QL provided the human specimen. CH and GL wrote the paper. DC and GL designed the research.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest for this manuscript.
Ethics Approval
All experimental protocols were approved by the Ethics Committee of The Xinqiao Hospital, Chongqing 40037, China (No. AF/SC-08/1.0). All procedures performed in studies involving human specimen were in accordance with the ethical standards.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Huang, C., Chen, D., Zhu, H. et al. LITAF Enhances Radiosensitivity of Human Glioma Cells via the FoxO1 Pathway. Cell Mol Neurobiol 39, 871–882 (2019). https://doi.org/10.1007/s10571-019-00686-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10571-019-00686-4